See more : Raízen S.A. (RAIZ4.SA) Income Statement Analysis – Financial Results
Complete financial analysis of Oncimmune Holdings plc (ONC.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Oncimmune Holdings plc, a leading company in the Biotechnology industry within the Healthcare sector.
- INTEGRA SWITCHGEAR LTD. (INTEGSW.BO) Income Statement Analysis – Financial Results
- Shenyang Cuihua Gold and Silver Jewelry Co., Ltd. (002731.SZ) Income Statement Analysis – Financial Results
- United Fiber Optic Communication Inc. (4903.TWO) Income Statement Analysis – Financial Results
- Steppe Gold Ltd. (STGO.TO) Income Statement Analysis – Financial Results
- Qinghai Spring Medicinal Resources Technology Co., Ltd. (600381.SS) Income Statement Analysis – Financial Results
Oncimmune Holdings plc (ONC.L)
About Oncimmune Holdings plc
Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a immunodiagnostic test for detecting and identifying lung cancer. The company also develops SeroTag, a platform that is used to discover and validate biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel. Oncimmune Holdings plc was incorporated in 2015 and is based in Nottingham, the United Kingdom.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.15M | 3.86M | 3.72M | 509.00K | 171.00K | 240.00K | 215.00K | 430.00K | 1.35M | 1.06M | 1.54M |
| Cost of Revenue | 360.00K | 2.40M | 865.00K | 537.00K | 1.03M | 917.00K | 532.00K | 147.00K | 3.00K | 141.00K | 137.00K |
| Gross Profit | 792.00K | 1.46M | 2.86M | -28.00K | -859.00K | -677.00K | -317.00K | 283.00K | 1.34M | 916.00K | 1.40M |
| Gross Profit Ratio | 68.75% | 37.76% | 76.76% | -5.50% | -502.34% | -282.08% | -147.44% | 65.81% | 99.78% | 86.66% | 91.07% |
| Research & Development | 1.26M | 1.52M | 1.62M | 1.68M | 1.50M | 800.00K | 1.03M | 789.00K | 617.00K | 1.09M | 1.27M |
| General & Administrative | 434.00K | 7.05M | 5.65M | 8.17M | 5.87M | 4.76M | 3.86M | 4.27M | 2.08M | 2.55M | 3.10M |
| Selling & Marketing | 3.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.78M | 7.05M | 5.65M | 8.17M | 5.87M | 4.76M | 3.86M | 4.27M | 2.08M | 2.55M | 3.10M |
| Other Expenses | 0.00 | 1.47M | 1.05M | -32.00K | 357.00K | 138.00K | 74.00K | 939.00K | 25.00K | 35.00K | 122.00K |
| Operating Expenses | 5.03M | 10.04M | 8.00M | 9.82M | 7.73M | 5.70M | 4.96M | 6.00M | 2.72M | 3.67M | 4.49M |
| Cost & Expenses | 5.39M | 12.45M | 8.87M | 10.36M | 8.76M | 6.61M | 5.49M | 6.14M | 2.73M | 3.81M | 4.63M |
| Interest Income | 204.00K | 6.40K | 403.00K | 111.00K | 52.00K | 48.00K | 26.00K | 5.00K | 15.00K | 176.00K | 2.00K |
| Interest Expense | 2.00M | 943.00K | 954.00K | 626.00K | 11.00K | 16.00K | 69.00K | 737.00K | 646.00K | 350.00K | 93.00K |
| Depreciation & Amortization | 981.00K | 197.00K | 740.00K | 500.00K | 239.00K | 180.00K | 91.00K | 78.00K | 41.00K | 41.00K | 191.00K |
| EBITDA | -4.43M | -7.16M | -4.48M | -8.97M | -8.30M | -6.15M | -5.16M | -8.19M | -1.33M | -1.20M | -2.90M |
| EBITDA Ratio | -384.64% | -185.46% | -107.52% | -1,814.54% | -4,852.63% | -2,560.83% | -2,398.14% | -1,309.53% | -98.59% | -240.11% | -188.86% |
| Operating Income | -4.24M | -8.59M | -5.15M | -9.27M | -8.59M | -6.37M | -5.27M | -5.71M | -1.38M | -2.76M | -3.09M |
| Operating Income Ratio | -368.23% | -222.49% | -138.23% | -1,820.83% | -5,022.81% | -2,655.83% | -2,452.56% | -1,328.84% | -102.75% | -260.64% | -201.43% |
| Total Other Income/Expenses | -1.69M | -943.00K | -551.00K | -515.00K | 41.00K | 32.00K | -43.00K | -3.29M | -631.00K | 1.16M | -91.00K |
| Income Before Tax | -5.93M | -9.53M | -5.70M | -9.78M | -8.55M | -6.34M | -5.32M | -9.01M | -2.01M | -1.59M | -3.18M |
| Income Before Tax Ratio | -514.58% | -246.93% | -153.04% | -1,922.00% | -4,998.83% | -2,642.50% | -2,472.56% | -2,094.88% | -149.67% | -150.71% | -207.36% |
| Income Tax Expense | 223.00K | -17.00K | -1.07M | -1.32M | -536.00K | -32.00K | -293.00K | -566.00K | 631.00K | -181.00K | -167.00K |
| Net Income | 4.10M | -9.51M | -4.63M | -8.46M | -8.01M | -6.31M | -5.02M | -8.44M | -2.01M | -1.41M | -3.02M |
| Net Income Ratio | 356.25% | -246.49% | -124.34% | -1,661.89% | -4,685.38% | -2,629.17% | -2,336.28% | -1,963.26% | -149.67% | -133.59% | -196.48% |
| EPS | 0.06 | -0.15 | -0.07 | -0.13 | -0.13 | -0.11 | -0.10 | -0.24 | -0.04 | -0.03 | -0.06 |
| EPS Diluted | 0.06 | -0.15 | -0.07 | -0.13 | -0.13 | -0.11 | -0.10 | -0.24 | -0.04 | -0.03 | -0.06 |
| Weighted Avg Shares Out | 72.51M | 64.55M | 64.57M | 63.30M | 61.78M | 55.56M | 51.02M | 35.87M | 51.02M | 51.02M | 51.02M |
| Weighted Avg Shares Out (Dil) | 72.51M | 64.55M | 64.57M | 63.30M | 61.78M | 55.56M | 51.02M | 35.87M | 51.02M | 51.02M | 51.02M |
Source: https://incomestatements.info
Category: Stock Reports